Stay updated on Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.

Latest updates to the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision label has been updated from v3.5.3 to v3.5.4, indicating a newer version of the page. This update does not modify the study details or surrounding content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, indicating an internal update to the site's infrastructure. It does not change the study details, eligibility criteria, or outcomes.SummaryDifference0.0%

- Check44 days agoChange DetectedFooter revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.0%

- Check80 days agoChange DetectedSite revision updated to v3.4.3, replacing the prior Revision: v3.4.2.SummaryDifference0.0%

- Check108 days agoChange DetectedFooter now displays Revision: v3.4.2 and the older government funding/operating status notices (v3.4.1) have been removed.SummaryDifference0.4%

Stay in the know with updates to Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.